LGC, Biosearch Technologies testing workflow underpins expansion of COVID-19 testing in New York

News (ZH) - Nexar workflow continues to enable simple, scalable, and cost-effective testing 

LGC’s SARS-CoV-2 ultra-high throughput End-Point PCR test EUA authorised by FDA

News (ZH) - Nexar™-based workflow enables simple, scalable, and cost-effective COVID-19 testing